Sibapriya Chaudhuri

At #AACR26 , reminded again of an entire community's unwavering commitment to finding cancer cures. Grateful to be part of this community

Nothing goes to waste! Best example being the python coding class I took years ago as an undergrad and now trying to remember the bits and pieces to analyze my latest transcriptomics dataset.

It is so humbling to play squash after 6 years and yet so oddly satisfying

At #AACR26, I will be presenting our latest preclinical findings. We show combined PARPi & ICB elicit differentially improved survival in BRCA1/2 vs CHEK2, ATM deficient TNBC by promoting an anti-tumor immune response through TLS formation. Let's connect if you are going

This women's day, let us talk about the growing trend of early onset of breast cancer in young women, especially in low-income countries where screening and support is less accessible. Let us raise awareness and make breast cancer history. Happy International Women's day!

Translational oncology research is hardly ever glamorous but it quietly transforms patient outcomes

@parametricarch Do you have data to share ? I could not find any on studio symbiosis website. Looking for data on how/ if AQI in these neighborhoods are better than other neighborhoods in Delhi. Of course, the neighborhoods have to equivalent in terms of population density, industry footprint.

1/3 VERTO, created by STUDIO SYMBIOSIS, is an air purification tower designed to maximize surface area, increase wind speed, and provide 360-degree air purification, located in New Delhi.

The clinical trials provide further support for our preclinical data

Leaving #SABCS25 with a lot of inspiration and gratitude. I hope to come back next year. Grateful to @bernmunster @munsterlab1 for introducing me to my first SABCS

What we, as oncology scientists have little control over is the cost and accessibility of the therapies that we are so rigorously and passionately designing. Another reason why unbiased research funding without an agenda is essential.

Disappointed to see @airindia reduce its direct flight options from SFO. Hoping to see better connectivity soon

At #SABCS25, we will present our preclinical findings & show how combined PARP inhibition and immune checkpoint blockade elicit differentially improved survival in HRD mutated breast cancer by promoting an anti-tumor immune response through TLS formation

Seeing the air quality reports from Delhi is honestly scary and unnerving. Let’s be real, pollution doesnt stay within borders. Instead of doomscrolling, maybe it’s time to ask, "what can I actually do to make a difference?"

For the patients who do respond to Keytruda, it’s nothing short of a miracle. The question that still remains - how do we find lesser known subsets of patients who would respond to checkpoint blockade and their spiked up combinations?

Happy International Men's day - to the men who have inspire us, cheer us on on, crack "dad" jokes and still make us laugh, and show up consistently with kindness.

Understanding end-of-life cancer biology. nature.com/articles/s4159… @Nature @NatureMedicine @NaturePortfolio #CancerResearch #PallOnc #CancerCare @Aiims1742

At #SITC25, we’ll be sharing our latest preclinical data on a novel combination immunotherapy for TNBC. I’ll be presenting new findings that reveal how specific mutations in the HRD pathway may predict best response to this therapy.

CRISPR has transformed preclinical studies by enabling generation of patient-specific mutations in isogenic backgr. Emerging data reveal a paradox: single "driver" mutation often fail to show expected drug response. Time we look at related mutations that occur together?

You are never too young to get cancer. The youngest person I know with MBC was diagnosed at age 18, in her senior year of high school. Stand up for yourself, advocate for yourself, and demand evaluation if something feels wrong!

Congratulations to the @NobelPrize in Medicine winners. As someone working on problems related to T cell tolerance, regulation and its role in cancer patients, the win feels very special.